Modifying ligand specificity of gene regulatory proteins

被引：8

作者：

Doyle, DF

Mangelsdorf, DJ

Corey, DR ^{[1
]}

机构：

[1] Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75235 USA

[2] Univ Texas, SW Med Ctr, Dept Biochem, Howard Hughes Med Inst, Dallas, TX 75235 USA

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 2000年 / 4卷 / 01期

关键词：

D O I：

10.1016/S1367-5931(99)00052-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Nuclear receptors contain a conserved hydrophobic ligand binding pocket that is particularly amenable to structure-based protein engineering. Thus, site-directed mutagenesis of the ligand binding pocket has resulted in the creation of nuclear receptors with novel ligand specificities. Such proteins are now being used to control gene expression in vivo in a ligand-dependent manner.

引用

收藏

页码：60 / 63

页数：4

相关论文

共 25 条

[1] Ligand-dependent regulation of plasmid-based transgene expression in vivo [J].

Abruzzese, RV ;

Godin, D ;

Burcin, M ;

Mehta, V ;

French, M ;

Li, YH ;

O'Malley, BW ;

Nordstrom, JL .

HUMAN GENE THERAPY, 1999, 10 (09) :1499-1507

[2] A SINGLE AMINO-ACID THAT DETERMINES THE SENSITIVITY OF PROGESTERONE RECEPTORS TO RU486 [J].

BENHAMOU, B ;

GARCIA, T ;

LEROUGE, T ;

VERGEZAC, A ;

GOFFLO, D ;

BIGOGNE, C ;

CHAMBON, P ;

GRONEMEYER, H .

SCIENCE, 1992, 255 (5041) :206-209

[3] CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].

BOURGUET, W ;

RUFF, M ;

CHAMBON, P ;

GRONEMEYER, H ;

MORAS, D .

NATURE, 1995, 375 (6530) :377-382

[4] Spatio-temporally controlled site-specific somatic mutagenesis in the mouse [J].

Brocard, J ;

Warot, X ;

Wendling, O ;

Messaddeq, N ;

Vonesch, JL ;

Chambon, P ;

Metzger, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14559-14563

[5] Adenovirus-mediated regulable target gene expression in vivo [J].

Burcin, MM ;

Schiedner, G ;

Kochanek, S ;

Tsai, SY ;

O'Malley, BW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) :355-360

[6] Selective estrogen receptor modulators: Clinical spectrum [J].

Cosman, F ;

Lindsay, R .

ENDOCRINE REVIEWS, 1999, 20 (03) :418-434

[7] Determinants of ligand specificity of estrogen receptor-α:: Estrogen versus androgen discrimination [J].

Ekena, K ;

Katzenellenbogen, JA ;

Katzenellenbogen, BS .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :693-699

[8] Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics [J].

Eng, FCS ;

Lee, HS ;

Ferrara, J ;

Willson, TM ;

White, JH .

MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4644-4653

[9] Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens [J].

Fink, BE ;

Mortensen, DS ;

Stauffer, SR ;

Aron, ZD ;

Katzenellenbogen, JA .

CHEMISTRY & BIOLOGY, 1999, 6 (04) :205-219

[10] Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists [J].

Géhin, M ;

Vivat, V ;

Wurtz, JM ;

Losson, R ;

Chambon, P ;

Moras, D ;

Gronemeyer, H .

CHEMISTRY & BIOLOGY, 1999, 6 (08) :519-529